Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer

View ORCID ProfileMasayuki Tsuneki, Makoto Abe, Shin Ichihara, Fahdi Kanavati
doi: https://doi.org/10.1101/2022.09.06.22279630
Masayuki Tsuneki
1Medmain Research, Medmain Inc., 2-4-5-104, Akasaka, Chuo-ku, Fukuoka, 810-0042, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masayuki Tsuneki
  • For correspondence: tsuneki{at}medmain.com
Makoto Abe
2Department of Pathology, Tochigi Cancer Center, 4-9-13 Yohnan, Utsunomiya, 320-0834, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shin Ichihara
3Department of Surgical Pathology, Sapporo Kosei General Hospital, 8-5 Kita-3-jo Higashi, Chuo-ku, Sapporo, 060-0033, Hokkaido, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fahdi Kanavati
1Medmain Research, Medmain Inc., 2-4-5-104, Akasaka, Chuo-ku, Fukuoka, 810-0042, Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Prostate cancer is often a slowly progressive indolent disease. Unnecessary treatments from overdiagnosis are a significant concern, particularly low-grade disease. Active surveillance has being considered as a risk management strategy to avoid potential side effects by unnecessary radical treatment. In 2016, American Society of Clinical Oncology (ASCO) endorsed the Cancer Care Ontario (CCO) Clinical Practice Guideline on active surveillance for the management of localized prostate cancer. Based on this guideline, we developed a deep learning model to classify prostate adenocarcinoma into indolent (applicable for active surveillance) and aggressive (necessary for definitive therapy) on core needle biopsy whole slide images (WSIs). In this study, we trained deep learning models using a combination of transfer, weakly supervised, and fully supervised learning approaches using a dataset of core needle biopsy WSIs (n=1300). We evaluated the models on a test set (n=645), achieving ROC-AUCs 0.846 (indolent) and 0.980 (aggressive). The results demonstrate the promising potential of deployment in a practical prostate adenocarcinoma histopathological diagnostic workflow system.

Competing Interest Statement

M.T. and F.K. are employees of Medmain Inc. All authors declare no competing interests.

Funding Statement

This study is based on results obtained from a project, JPNP14012, subsidized by the New Energy and Industrial Technology Development Organization (NEDO).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The experimental protocol was approved by the ethical board of Kamachi Group Hospitals (No. 173) and Sapporo-Kosei General Hospital (No. 597). All research activities complied with all relevant ethical regulations and were performed in accordance with relevant guidelines and regulations in the all hospitals mentioned above. Informed consent to use histopathological samples and pathological diagnostic reports for research purposes had previously been obtained from all patients prior to the surgical procedures at all hospitals, and the opportunity for refusal to participate in research had been guaranteed by an opt-out manner.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets generated during and/or analysed during the current study are not publicly available due to specific institutional requirements governing privacy protection but are available from the corresponding author on reasonable request. The datasets that support the findings of this study are available from Kamachi Group Hospitals (Fukuoka, Japan) and Sapporo-Kosei General Hospital (Sapporo, Japan), but restrictions apply to the availability of these data, which were used under a data use agreement which was made according to the Ethical Guidelines for Medical and Health Research Involving Human Subjects as set by the Japanese Ministry of Health, Labour and Welfare (Tokyo, Japan), and so are not publicly available. However, the data are available from the authors upon reasonable request for private viewing and with permission from the corresponding medical institutions within the terms of the data use agreement and if compliant with the ethical and legal requirements as stipulated by the Japanese Ministry of Health, Labour and Welfare.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 06, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer
Masayuki Tsuneki, Makoto Abe, Shin Ichihara, Fahdi Kanavati
medRxiv 2022.09.06.22279630; doi: https://doi.org/10.1101/2022.09.06.22279630
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer
Masayuki Tsuneki, Makoto Abe, Shin Ichihara, Fahdi Kanavati
medRxiv 2022.09.06.22279630; doi: https://doi.org/10.1101/2022.09.06.22279630

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)